COHERUS BIOSCIENCES INC. - COMMON STOCK
2.1200
17-5月-24 15:59:59
15 分の遅延
株式
-0.0500
-2.30%
本日の幅
2.1000 - 2.2100
ISIN
N/A
ソース
NASDAQ
-
NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK
02 10 2023 15:02:53 提供 NetDania Notify
-
Coherus Applauds Congressional Designation of September 30th as Rare Cancer Day
02 10 2023 09:00:00 提供 Nasdaq GlobeNewswire
-
27 9 2023 09:10:29 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
22 9 2023 21:00:00 提供 Nasdaq GlobeNewswire
-
Coherus Completes Surface Oncology Acquisition
08 9 2023 09:05:40 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences to Participate at Upcoming September Investor Conferences
01 9 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
22 8 2023 17:35:22 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
02 8 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Second Quarter 2023 Financial Results on August 02, 2023
26 7 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
21 7 2023 17:30:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors
20 7 2023 16:04:53 提供 Nasdaq GlobeNewswire
-
Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
13 7 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.
03 7 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
26 6 2023 21:08:00 提供 Nasdaq GlobeNewswire
-
Coherus to Acquire Surface Oncology
16 6 2023 07:01:00 提供 Nasdaq GlobeNewswire
-
05 6 2023 17:30:00 提供 Nasdaq GlobeNewswire
-
01 6 2023 08:33:07 提供 Nasdaq GlobeNewswire
-
01 6 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK
31 5 2023 10:02:15 提供 NetDania Notify